BioCentury
ARTICLE | Clinical News

Clavis preclinical data

May 18, 2009 7:00 AM UTC

In vitro, CP-4200 increased re-constitution of normal cell function, reduced dependency of multidrug resistance, improved cellular uptake and demonstrated a rapid onset of activity compared to Vidaza...